Lumipulse® sTREM2 Controls
These controls are intended for use as an assayed quality control to monitor the precision and accuracy of laboratory testing procedures for the analysis of soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in human serum, plasma and cerebrospinal fluid (CSF) on the automated LUMIPULSE® G System.
This product is not for use in diagnostic procedures, for ‘Research Use Only’.
Product # 81658
-
Documentation
Browse regulatory documents for this product
Create a free membership account and start browsing all product documentation right away.
Get access to this section and more
Create a membership account to review and download product-specific documentation.
-
Insights
Jun 18, 2026USA Today Article - A Blood Test for Alzheimer’s? Yes — And Here’s Why It Matters
With Alzheimer’s disease affecting millions of Americans, clinicians need practical diagnostic tools. Blood‑based biomarkers are gaining attention as...
May 5, 2026Medical Laboratory Observer (MLO) Article - From imaging to blood: Alzheimer’s diagnostics evolve
Alzheimer’s disease (AD) is the major cause of dementia worldwide that leads to morbidity, long‑term care utilization, and significant healthcare...
Mar 31, 2026Integration of ADx NeuroSciences Within Fujirebio Unleashes a World of New Possibilities
Fujirebio Europe N.V. will formally and fully integrate ADx NeuroSciences N.V. into its organization on April 1, 2026. This completes a process that...
-
Product inquiry
Powered by Bioz
